米乐m6
米乐m6:About Henlius
米乐m6:Company Profile
米乐m6:Corporate Culture
Honor
米乐m6:Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
米乐m6:Science & Technology
R&D Result
米乐m6:Innovation Centre
Technology Platform
Quality Management
Manufacturing
米乐m6:Collaborations
米乐m6:Investor Relations
米乐m6:Information Disclosure
米乐m6:Corporate Governance
Financial Reports
米乐m6:Stock Info
米乐m6:IR Calendar
米乐m6:Investor Presentation
Analyst Coverage
Contact Information
Media
米乐m6:Press Release
Multi-media
米乐m6:Media Reports
米乐m6:Media Enquiry
Careers
米乐m6:Talent Philosophy
米乐m6:Staff Life
Training and Development
Contact Us
米乐m6:Contact Information
Customer Message
Privacy
米乐m6:Legal Statement
Compliance
EN
简体
EN
繁體
Home
About Henlius
Company Profile
米乐m6:Corporate Culture
Honor
米乐m6:Board of Directors
米乐m6:Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
米乐m6:R&D Result
米乐m6:Innovation Centre
米乐m6:Technology Platform
米乐m6:Quality Management
Manufacturing
Collaborations
米乐m6:Investor Relations
米乐m6:Information Disclosure
米乐m6:Listing Documents
Announcement & Circulars
米乐m6:Corporate Governance
Financial Reports
米乐m6:Stock Info
IR Calendar
Investor Presentation
米乐m6:Analyst Coverage
米乐m6:Contact Information
Media
Press Release
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Event
米乐m6:Popular Science
米乐m6:Media Reports
Media Enquiry
Careers
Talent Philosophy
米乐m6:Staff Life
Training and Development
米乐m6:Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
米乐m6:Compliance
Be the most trusted biotech company
米乐m6:Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
米乐m6:Multi-media
Company
米乐m6:Popular Science
米乐m6:Highlights
Download
Media Reports
米乐m6:Media Enquiry
2018-11-29
sh13168.completed Data Analysis of the Phase 1 Study for Its HLX03
2018-11-26
Henlius HLX22 Received IND Application Acceptance Notification from NMPA
2018-11-16
Henlius Successfully Held Its Second Scientific Advisory Board (SAB) Meeting in California
2018-11-01
Cooperation Upgrades! Henlius Has been Granted to Develop and Commercialize AC101 in the World
2018-10-26
New Progress! Henlius Received Clinical Approval for Its Anti-VEGFR2 Monoclonal Antibody, HLX12
2018-10-18
Henlius Nominated for the Global Generics & Biosimilars Awards 2018 in Two Categories
2018-09-10
Important News! sh13168.combination Therapy Received Approval to Conduct Clinical Trials in China
2018-08-09
Henlius Submitted Investigational New Drug Application for Its HLX12
2018-06-21
Henlius and Accord Entered into an License Agreement for HLX02
1
2
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
米乐m6登录 - m6平台 - 米乐m6
米乐m6 - 米乐m6登陆
米乐m6app下载
米乐m6平台 - 官方下载 - 米乐m6在线登录
一分赛车_米乐m6_一分赛车官网